SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-668383
Filing Date
2016-08-02
Accepted
2016-08-02 16:24:51
Documents
40
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d208387d10q.htm 10-Q 242473
2 EX-4.1 d208387dex41.htm EX-4.1 16600
3 EX-31.1 d208387dex311.htm EX-31.1 6730
4 EX-31.2 d208387dex312.htm EX-31.2 6678
5 EX-32.1 d208387dex321.htm EX-32.1 4696
12 GRAPHIC g208387ex41pg001.jpg GRAPHIC 550935
  Complete submission text file 0001193125-16-668383.txt   2319184

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT oxgn-20160630.xml EX-101.INS 247058
7 XBRL TAXONOMY EXTENSION SCHEMA oxgn-20160630.xsd EX-101.SCH 21659
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxgn-20160630_cal.xml EX-101.CAL 25817
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oxgn-20160630_def.xml EX-101.DEF 41579
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE oxgn-20160630_lab.xml EX-101.LAB 181570
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oxgn-20160630_pre.xml EX-101.PRE 116269
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 161800805
SIC: 2836 Biological Products, (No Diagnostic Substances)